ICD-10-CM Diagnosis Code D02.2 - Carcinoma in situ of bronchus and lung (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- C00–D49
- D00-D09
- D02
- 2026 ICD-10-CM Code D02.2
Carcinoma in situ of bronchus and lung
ICD-10-CM Code:
D02.2
ICD-10 Code for:
Carcinoma in situ of bronchus and lung
Is Billable?
Not Valid for Submission
Code Navigator:
D02.2 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity from the list below for a diagnosis of carcinoma in situ of bronchus and lung. The code is not specific and is NOT valid for the year 2026 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bronchiogenic, bronchogenic (lung) ; Neoplasm, neoplastic bronchiole ; Neoplasm, neoplastic bronchus ; Neoplasm, neoplastic bronchus carina ; Neoplasm, neoplastic bronchus lower lobe of lung ; Neoplasm, neoplastic bronchus main ; Neoplasm, neoplastic bronchus upper lobe of lung ; etc
Non-specific codes like D02.2 require more digits to indicate the appropriate level of specificity. Consider using any of the following billable codes with a higher level of specificity when coding for carcinoma in situ of bronchus and lung:
Use D02.20 for Carcinoma in situ of unspecified bronchus and lung
Use D02.21 for Carcinoma in situ of right bronchus and lung
Use D02.22 for Carcinoma in situ of left bronchus and lung
- Code Information
- Specific Coding
- Tabular List of Diseases and Injuries
- Table of Neoplasms
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Neoplasms
C00–D49
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Filter table of neoplasms:
| Neoplasm, neoplastic | Malignant Primary | Malignant Secondary | CaInSitu | Benign | Uncertain Behavior | Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »bronchiogenic, bronchogenic (lung) | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchiole | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchus | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchus »carina | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchus »lower lobe of lung | C34.3 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchus »main | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »bronchus »upper lobe of lung | C34.1 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »carina (bronchus) | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »hilus of lung | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lingula, lung | C34.1 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »azygos lobe | C34.1 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »carina | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »hilus | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »lingula | C34.1 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »lobe NEC | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »lower lobe | C34.3 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »main bronchus | C34.0 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »lung »upper lobe | C34.1 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »pulmonary [See Also: Neoplasm, lung] | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
| »Neoplasm, neoplastic »subpleural | C34.9 | C78.0 | D02.2 | D14.3 | D38.1 | D49.1 |
Lung Cancer
What is lung cancer?
Lung cancer is cancer that forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
There are two main types: small cell lung cancer and non-small cell lung cancer. These two types grow differently and are treated differently. Non-small cell lung cancer is the more common type.
Who is more likely to develop lung cancer?
Anyone can develop lung cancer, but certain factors raise your risk of getting it:
- Smoking. This is the most important risk factor for lung cancer. Tobacco smoking causes about 9 out of 10 cases of lung cancer in men and about 8 out of 10 cases of lung cancer in women. The more years you smoke and the more cigarettes you smoke each day, the more your risk goes up. Your risk is also greater if you smoke a lot and drink alcohol every day or take beta carotene supplements. If you have quit smoking, your risk will be lower than if you had kept smoking. But you will still have a higher risk than people who never smoked.
- Secondhand smoke, which is the combination of the smoke that comes from a cigarette and the smoke breathed out by a smoker. When you breathe in secondhand smoke, you are exposed to the same cancer-causing agents as smokers, although in smaller amounts.
- A family history of lung cancer.
- Being exposed to asbestos, arsenic, chromium, beryllium, nickel, soot, or tar in the workplace.
- Being exposed to radiation, for example from:
- Radiation therapy to the breast or chest
- Radon in the home or workplace
- Certain imaging tests such as CT scans
- HIV infection. Your risk is higher if you have HIV. However, smoking rates are higher in people who have HIV, so it's not clear whether the increased risk is from the HIV infection or from smoking.
- Air pollution. Studies show that living in areas with higher levels of air pollution increases your risk of lung cancer.
What are the symptoms of lung cancer?
Lung cancer may not cause any signs or symptoms until the cancer is advanced. Sometimes the cancer is found during a chest x-ray done for another condition.
The symptoms of lung cancer may include:
- Chest pain or discomfort
- A cough that doesn't go away or gets worse over time
- Coughing up blood
- Trouble breathing
- Wheezing
- Hoarseness
- Loss of appetite
- Weight loss for no known reason
- Feeling very tired
- Trouble swallowing
- Swelling in the face and/or veins in the neck
How is lung cancer diagnosed?
To find out if you have lung cancer, your health care provider:
- Will take your medical history, which includes asking about your symptoms
- Will ask about your family history
- Will do a physical exam
- May order certain imaging tests, such as a chest x-ray or chest CT scan
- May order lab tests, including tests of your blood and sputum
- May do a procedure to take a biopsy of the lung
If you do have lung cancer, your provider will do other tests to find out if it has spread through the lungs, lymph nodes, and the rest of the body. This is called staging. Knowing the type and stage of lung cancer you have helps your provider decide what kind of treatment you need.
If you have small-cell lung cancer, your provider may also do genetic testing to look for certain gene changes (variants) in your cancer cells. The results of the testing may help guide treatment.
What are the treatments for lung cancer?
For most patients with lung cancer, current treatments do not cure the cancer.
Your treatment will depend on which type of lung cancer you have, how far it has spread, your overall health, and other factors. You may get more than one type of treatment.
The treatments for small cell lung cancer may include:
- Surgery.
- Chemotherapy.
- Radiation therapy.
- Immunotherapy.
- Laser therapy, which uses a laser beam to kill cancer cells.
- Endoscopic stent placement. An endoscope is a thin, tube-like instrument used to look at tissues inside the body. It may be used to put in a device called a stent. The stent helps to open an airway that has been blocked by abnormal tissue.
The treatments for non-small cell lung cancer may include:
- Surgery.
- Radiation therapy.
- Chemotherapy.
- Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
- Immunotherapy.
- Laser therapy.
- Photodynamic therapy (PDT), which uses a medicine and a certain type of laser light to kill cancer cells.
- Cryosurgery, which uses an instrument to freeze and destroy abnormal tissue.
- Electrocautery, a treatment that uses a probe or needle heated by an electric current to destroy abnormal tissue.
Can lung cancer be prevented?
Avoiding the risk factors may help prevent lung cancer. For example, you can:
- Quit smoking. And if you don't smoke, don't start.
- Lower your exposure to hazardous substances at work.
- Lower your exposure to radon. Radon tests can show whether your home has high levels of radon. You can buy a test kit yourself or hire a professional to do the test.
NIH: National Cancer Institute
Lung Cancer-Patient Version
Learn about lung cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]
Non-Small Cell Lung Cancer Summary
Learn about non-small cell lung cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
